Nanjing Well Pharmaceutical Group (SHA:603351) completed the process of updating its business registration after expanding its business scope, according to a Shanghai bourse filing on Wednesday.
The company received the renewed business license from China's Nanjing Municipal Administration for Market Regulation.
The pharmaceutical company's shares rose 2% at the close.